Parallax Volatility Advisers’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,766
| Closed | -$296K | – | 1783 |
|
|
2024
Q4 | $296K | Buy |
+8,766
| New | +$316K | ﹤0.01% | 1607 |
|
|
2024
Q1 | – | Sell |
-64,180
| Closed | -$2.65M | – | 2024 |
|
|
2023
Q4 | $2.38M | Sell |
64,180
-5,875
| -8% | -$211K | ﹤0.01% | 1109 |
|
|
2023
Q3 | $2.54M | Buy |
70,055
+8,363
| +14% | +$297K | 0.01% | 1009 |
|
|
2023
Q2 | $2.2M | Buy |
61,692
+43,259
| +235% | +$1.55M | ﹤0.01% | 1102 |
|
|
2023
Q1 | $656K | Buy |
+18,433
| New | +$645K | ﹤0.01% | 1656 |
|
|
2022
Q4 | – | Sell |
-67,337
| Closed | -$2.24M | – | 3033 |
|
|
2022
Q3 | $1.98M | Sell |
67,337
-12,762,447
| -99% | -$484M | ﹤0.01% | 1434 |
|
|
2022
Q2 | $1.53B | Buy |
+12,829,784
| New | +$708M | 1.46% | 13 |
|
|
2021
Q1 | – | Sell |
-9,351
| Closed | -$430K | – | 1462 |
|
|
2020
Q4 | $430K | Buy |
9,351
+5,129
| +121% | +$236K | ﹤0.01% | 1698 |
|
|
2020
Q3 | $199K | Buy |
4,222
+3,707
| +720% | +$186K | ﹤0.01% | 2549 |
|
|
2020
Q2 | $26K | Buy |
+515
| New | +$26.4K | ﹤0.01% | 2560 |
|
|
2020
Q1 | – | Sell |
-135
| Closed | -$8K | – | 2542 |
|
|
2019
Q4 | $8K | Buy |
+135
| New | +$7.51K | ﹤0.01% | 2338 |
|
|
2019
Q3 | – | Sell |
-9
| Closed | – | – | 2769 |
|
|
2019
Q2 | $0 | Buy |
+9
| New | +$452 | ﹤0.01% | 3017 |
|
|
2019
Q1 | – | Sell |
-3,695
| Closed | -$185K | – | 3245 |
|
|
2018
Q4 | $176K | Buy |
+3,695
| New | +$182K | ﹤0.01% | 1776 |
|
|
2018
Q1 | – | Sell |
-45
| Closed | -$2.1K | – | 3040 |
|
|
2017
Q4 | $2K | Buy |
+45
| New | +$2.08K | ﹤0.01% | 3861 |
|
|
2016
Q1 | – | Sell |
-14,794
| Closed | -$746K | – | 2965 |
|
|
2015
Q4 | $746K | Buy |
+14,794
| New | +$754K | ﹤0.01% | 1382 |
|
|
2014
Q1 | – | Sell |
-36,190
| Closed | -$2.42M | – | 3482 |
|
|
2013
Q4 | $2.42M | Buy |
36,190
+21,245
| +142% | +$1.38M | 0.01% | 616 |
|
|
2013
Q3 | $937K | Buy |
+14,945
| New | +$962K | ﹤0.01% | 686 |
|
Other funds holding GSK
JEST
